Back to search
Non-gastric Marginal Zone Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-gastric Marginal Zone Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-gastric Marginal Zone Lymphoma trials you may qualify forThis first-in-human (FIH) trial is designed to assess the safety, feasibility and preliminary efficacy of a single intravenous (IV) dose of SynKIR-310 administe…
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or rec…
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial…
This trial studies the effectivity of low-dose radiation therapy with 10x2Gy for the treatment of patients with stage I-II stomach or duodenal Lymphoma (Margina…
We hypothesized that a proportion of patients with localized Helicobacter pylori-negative gastric MALT lymphoma may well respond to frontline Helicobacter pylor…
The purpose of this study is to determine the safety and tolerability of intravenous (IV) and subcutaneous (SC) administration of XmAb13676 and to determine the…